Deborah Wenkert - Net Worth and Insider Trading
Deborah Wenkert Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Deborah Wenkert owns 1 companies in total, including Inozyme Pharma Inc (INZY) .
Click here to see the complete history of Deborah Wenkert’s form 4 insider trades.
Insider Ownership Summary of Deborah Wenkert
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| INZY | Inozyme Pharma Inc | 2021-02-02 | SVP & CMO |
Deborah Wenkert Trading Performance
Deborah Wenkert Ownership Network
Ownership Network List of Deborah Wenkert
Ownership Network Relation of Deborah Wenkert
Deborah Wenkert Owned Company Details
What does Inozyme Pharma Inc do?
Who are the key executives at Inozyme Pharma Inc?
Deborah Wenkert is the SVP & CMO of Inozyme Pharma Inc. Other key executives at Inozyme Pharma Inc include director & 10 percent owner Robert Lorne Hopfner , COO Matthew Winton , and See Remarks Henric Bjorn Bjarke .
Inozyme Pharma Inc (INZY) Insider Trades Summary
Over the past 18 months, Deborah Wenkert made no insider transaction in Inozyme Pharma Inc (INZY). Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net purchase of 833,333 shares made by Robert Lorne Hopfner , a net purchase of 833,333 shares made by Pivotal Bioventure Partners Fund I G.p., L.p. , and a net sale of 7,523 shares made by Douglas A Treco .
In summary, during the past 3 months, insiders sold 0 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,523 shares of Inozyme Pharma Inc (INZY) were sold and 1,666,666 shares were bought by its insiders, resulting in a net purchase of 1,659,143 shares.
Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inozyme Pharma Inc Insider Transactions
Deborah Wenkert Mailing Address
Above is the net worth, insider trading, and ownership report for Deborah Wenkert. You might contact Deborah Wenkert via mailing address: C/o Inozyme Pharma, Inc., 321 Summer Street, Suite 400, Boston Ma 02210.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
